Advertisement
Screener

Krystal Biotech, Inc. (KRYS) ROA

Krystal Biotech, Inc. (KRYS) ROA

  • 2026-06-30: ROA 16.09%.
  • 2026-03-31: ROA 16.11%.
  • 2025-12-31: ROA 15.36%.
  • 2025-09-30: ROA 16.04%.

Complete source-backed roa history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-3016.09%
2026-03-3116.11%
2025-12-3115.36%
2025-09-3016.04%
2025-06-3012.89%
2025-03-3111.54%
2024-12-318.44%
2024-09-305.33%
2024-06-3011.54%
2024-03-316.70%
2023-12-311.34%
2023-09-30-3.77%
2023-06-30-20.53%
2023-03-31-25.44%
2022-12-31-25.06%
2022-09-30-22.51%
2022-06-30-19.20%
2022-03-31-16.81%
2021-12-31-11.11%
2021-09-30-12.89%
2021-06-30-11.76%
2021-03-31-9.62%
2020-12-31-10.35%
2020-09-30-8.71%
2020-06-30-6.85%
2020-03-31-9.90%
2019-12-31-9.13%
2019-09-30-8.14%
2019-06-30-7.76%
2019-03-31-11.11%
2018-12-31-9.38%
2018-09-30-15.75%
2018-06-30-24.10%
2018-03-31-20.01%
2017-12-31-15.80%
2017-09-30-13.58%

Annual ROA

DateROA
2025-12-3115.36%
2024-12-318.44%
2023-12-311.34%
2022-12-31-25.06%
2021-12-31-11.11%
2020-12-31-10.35%
2019-12-31-9.13%
2018-12-31-9.38%
2017-12-31-15.80%
2016-12-31-52.70%

Similar stocks

Stock NameCountryMarket CapPE Ratio
REPLIGEN CORP (RGEN)United States$10.755B185.31
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Immunovant, Inc. (IMVT)United States$7.028B-14.78
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
CG Oncology, Inc. (CGON)United States$6.095B-27.95